Progesterone Levels Post-Menopause: What Women in Centennial Should Know
Many postmenopausal women—and, frankly, many physicians—focus almost exclusively on estrogen when discussing hormone replacement therapy after menopause. Progesterone, however, plays an equally important role in the postmenopausal hormonal picture. For women in Centennial, Colorado and the surrounding South Denver suburbs who are exploring BHRT or already on estrogen therapy, understanding what happens to progesterone after menopause—and why it matters—is essential.
What Happens to Progesterone After Menopause?
Progesterone is produced primarily by the corpus luteum—the temporary glandular structure that forms in the ovary after ovulation. Because postmenopausal women no longer ovulate, the primary source of ovarian progesterone is eliminated. While small amounts of progesterone continue to be produced by the adrenal glands after menopause, these levels are minimal—often falling below 0.5 ng/mL in serum, compared to the 5–20 ng/mL range typical during the luteal phase of the premenopausal cycle.
This near-complete loss of progesterone is often underappreciated in standard menopausal care. When estrogen replacement is initiated without progesterone in women who have a uterus, progesterone (or a progestin) is added primarily to protect against endometrial hyperplasia—the overgrowth of the uterine lining that can occur with unopposed estrogen and that can progress to endometrial cancer. This protective role is well-established and important. But progesterone's role in postmenopausal health extends far beyond endometrial protection.
Progesterone's Broader Role in Postmenopausal Health
Sleep quality: Progesterone is converted in the brain to allopregnanolone, a potent positive allosteric modulator of GABA-A receptors—the same receptor system targeted by benzodiazepines and sleep medications. This neurosteroid action produces sedative and anxiolytic effects that support sleep onset and maintenance. Many postmenopausal women report significant improvement in sleep quality after initiating oral bioidentical progesterone at bedtime, and this is one of the most consistently observed benefits of progesterone therapy.
Mood and anxiety: The allopregnanolone pathway that supports sleep also calms anxiety, reduces irritability, and contributes to emotional resilience. Progesterone deficiency after menopause frequently manifests as worsening anxiety, mood instability, and an increased stress response—symptoms that are often attributed to estrogen deficiency when progesterone deficiency is the primary driver.
Bone density: Progesterone stimulates osteoblast activity—the bone-building cells responsible for laying down new bone matrix. While estrogen primarily prevents bone resorption (breakdown), progesterone actively promotes bone formation. This complementary mechanism suggests that the combination of estrogen and progesterone may provide greater bone protection than estrogen alone.
Breast tissue: This is one of the most clinically significant distinctions between bioidentical progesterone and synthetic progestins. The E3N cohort study—a large French observational study of over 80,000 postmenopausal women—found that estrogen combined with bioidentical progesterone was not associated with increased breast cancer risk, in contrast to estrogen combined with synthetic progestins (MPA), which was associated with a 40% increased risk. This finding has been replicated in several other large observational studies and is a major reason why bioidentical progesterone is preferred by many hormone specialists.
Cardiovascular health: Bioidentical progesterone does not appear to have the adverse lipid effects (lowering HDL cholesterol) associated with some synthetic progestins. It also does not appear to blunt the cardiovascular benefits of estrogen in the way that MPA does—an important consideration for women using HRT for cardiovascular risk reduction as well as symptom relief.
Thyroid function: Progesterone supports thyroid hormone receptor sensitivity and helps counteract the thyroid-suppressing effects of estrogen dominance. Women with subclinical hypothyroidism may notice improved thyroid-related symptoms when progesterone is properly balanced with estrogen.
Testing Progesterone After Menopause
Measuring progesterone after menopause requires appropriate specimen selection. Serum progesterone is the standard test for women not on topical progesterone, with postmenopausal levels expected to be very low (less than 1 ng/mL). For women using topical (cream) progesterone, serum testing may not accurately reflect tissue levels—some clinicians prefer dried urine testing or salivary testing in this context. Oral bioidentical progesterone produces measurable serum levels that can be tracked with standard blood tests.
Accessing BHRT Near Centennial, Colorado
Centennial residents are well-positioned to access Dr. Bruice's Denver-area hormone clinic. Dr. Bruice's Denver location is approximately 20–25 minutes from Centennial via I-25 North, making expert BHRT care accessible without a lengthy commute.
Dr. Bruice specializes in comprehensive postmenopausal hormone care, including bioidentical estradiol and progesterone therapy, testosterone optimization, and thyroid management—providing Centennial women with the personalized, evidence-based BHRT they deserve. If you are a postmenopausal woman in Centennial and want a thorough evaluation of your progesterone and overall hormonal status, contact Dr. Bruice's office today to schedule a consultation.